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Abstract 
The functional diversity of proteins is a major factor determining the complexity of cells and 
tissues. Both translational and post-translational modifications contribute to this diversity. Recently, 
protein unfolding and refolding has been recognised as another mechanism for diversity by 
unmasking buried or cryptic sequences (epitopes) that possess physiological functions. In the 
current review, we focus on extracellular proteins where folding dynamics can be influenced by 
mechanical forces, protein-protein interactions and denaturation. Many cryptic epitopes in these 
proteins are exposed following proteolytic cleavage, but recent data indicate that 
unfolding/refolding play an important role in regulating the physiological behaviour of extracellular 
proteins. By understanding how and when hidden sequences are exposed, novel techniques for 
manipulating the function of these proteins may be uncovered. 
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1. Introduction 
 
Proteins are essential to all aspects of cellular function. They catalyse enzymatic reactions, 
regulate gene expression and ion transport, communicate between the extracellular environment and 
the intracellular space, control the structure, shape and mobility of cells, and modulate the 
movement of cells within tissues. A single gene can encode a protein with diverse functions 
depending on various events such as alternative splicing, post-translational modifications and 
compartmentalisation. Some proteins perform multiple tasks that are mechanistically distinct 
(moonlighting). For example, pyruvate kinase carboxylates pyruvate but, in some species, it also 
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acts as a transporter for other proteins (Ozimek et al., 2003). Similarly, cytochrome C participates in 
mitochondrial electron transport but, in the cytosol, it forms a complex with Apaf-1 to initiate 
apoptosis (Hao et al., 2005). There are numerous examples of these multi-purpose proteins (Huberts 
and van der Klei, 2010). The different translational and post-translational modifications that a 
protein can undergo gives rise to functional diversity that contributes to the biological complexity of 
cells and tissues. In recent years, subtle changes in protein structure due to induced unfolding and 
refolding has been recognised as a further contributor to this functional diversity (Uversky, 2015). 
The vast array of functions that proteins perform is enabled by the precise folding of an 
amino acid sequence into a specific but dynamic three-dimensional conformation. Differences 
between structural elements distinguish one protein from another and represent the most 
fundamental property affecting the biological activity of proteins. Correct biological functionality 
requires a protein to exist in its native conformation. Misfolding can lead to proteopathy, diseases 
caused by protein aggregation, which include amyloidosis, Alzheimer’s disease, amyotrophic lateral 
sclerosis, tauopathies, retinitis pigmentosa, Huntington’s disease and Parkinson’s disease.  
Proteins are structurally dynamic with ordered and disordered regions that unfold and refold 
over time and in response to various stimuli (Jakob et al., 2014). It has been widely reported that 
changes in the folding state of a protein can expose functional domains normally hidden or shielded 
within the protein. This has been best illustrated by antibody recognition of various antigenic 
determinants (epitopes) in misfolded proteins (Sela-Culang et al., 2013). Epitopes can be specific 
sequences (linear peptides) or motifs comprised of several structural elements in close proximity. 
Upon unfolding of a protein, the antigenic site (cryptic epitope) is exposed and elicits an 
immunological reaction (Laver et al., 1990). This is the basis for many auto-immune diseases. For 
example, the plasma transport protein transthyretin is involved in several forms of amyloidosis. 
Following unfolding and aggregation of transthyretin (Goldsteins et al., 1999; Phay et al., 2014), a 
normally buried -strand is exposed (Gustavsson et al., 1994). Moreover, antibodies to this -strand 
are common in patients with transthyretin amyloidosis but not in controls. The influenza coat 
protein hemagglutinin is another well-characterised example of a molecule that partially unfolds in 
order to elicit a biological effect, in this case, fusion with the endosomal membrane during infection 
(Huang et al., 2003). 
While our understanding of cryptic epitope recognition by antibodies is well established, 
recently evidence has begun to emerge that similar hidden sequences responsible for non-antigenic 
biological activities are present in some proteins. This is particularly evident in extracellular matrix 
proteins (Schenk and Quaranta, 2003) where exposure of these buried motifs, referred to as 
‘matricryptic’ sites, involves conformational changes and/or proteolytic cleavage (Davis et al., 
2000). Some of these are central to the primary role of the protein while others create novel 
functions that are not obvious unless the buried peptide sequence is exposed. These cryptic epitopes 
increase the functional diversity of many extracellular and intracellular proteins (Fig 1). The 
difficulties in identifying functional cryptic epitopes are well reported but recent studies into the 
effects of protein binding to nanomaterials suggest a model for partially unfolding proteins that can 
be used to study their altered biological effects (Deng et al., 2011; Mortimer et al., 2014). The 
current review briefly summarises recent advances in our understanding of functional diversity 
focussing on key extracellular proteins.  
 
2. Learning from extracellular matrix proteins: Matricryptic sites 
 
Extracellular matrix proteins commonly carry out multiple and diverse biological functions, 
many of which are the result of cryptic site exposure (Maquart et al., 2004). Although these masked 
sequences can be activated following either proteolytic cleavage or conformational modifications 
(Davis et al., 2000; Tran et al., 2005), discussion here will focus on the latter. Readers are directed 
to other reviews that cover examples of cryptic sites in extracellular matrix proteins revealed by 
enzymatic digestion (Davis et al., 2000; Schenk and Quaranta, 2003). Exposure of bioactive sites by 
conformational modifications can be induced by several different mechanisms including mechanical 
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force (Hocking et al., 2008), heterotypic binding to other molecules (Dardik and Lahav, 1999), self-
assembly reactions (Mao and Schwarzbauer, 2005; Wierzbicka-Patynowski and Schwarzbauer, 
2003), and denaturation. The unmasking of cryptic epitopes by molecular stretching has been well 
characterised for intracellular proteins such as talin and alpha-catenin (del Rio et al., 2009; 
Yonemura et al., 2010).  
An important point for consideration regarding cryptic sites in extracellular matrix proteins 
is the gain in functionality. This is highlighted in work linking matricryptic site exposure and cell 
responses following tissue injury (Davis, 2010). Matricryptic sites can also be similar to those of 
pattern recognition receptors. For instance, DMBT1 (a basement membrane matrix protein also 
referred to as hesin) binds polyanionic ligands including LPS in a similar manner as scavenger 
receptors (End et al., 2009). It has been proposed that unmasking of these site that engage pattern 
recognition receptors helps regulate cell responses during tissue injury (Davis, 2010). 
 
2.1. Collagen 
 
Collagens are the most abundant proteins in the extracellular space involved in the 
organisation of the structural support to surrounding cells throughout the body (Di Lullo et al., 
2002). Collagen has multiple diverse biological effects such as inhibition of angiotensin 1-
converting enzyme (ACE), anti-angiogenesis activity, tumor growth inhibition, chemotaxis and 
oxidative stress relief (Banerjee et al., 2015). Cryptic binding sites contribute substantially to this 
functional diversity. The majority of these sites require proteolytic activation (Marneros and Olsen, 
2001; Sasaki et al., 2002).  However, conformational changes to collagen can also expose hidden 
binding domains. For instance, the pro-angiogenic HUIV26 cryptic epitope within the triple helix of 
collagen IV can be exposed by temperature-induced unfolding (Hangai et al., 2002; Xu et al., 2001) 
as well as ionizing radiation (Brooks et al., 2002). This motif has been linked to several biological 
effects of collagen, including cell migration, adhesion and angiogenesis (Favreau et al., 2014; Xu et 
al., 2001). Despite attempts to identify the HUIV26 epitope, the amino acid sequence remains 
unknown suggesting it may represent a non-contiguous binding domain. Importantly, this epitope 
has been shown to have a role in tumour metastasis and may be a novel target for drug development 
(Roth et al., 2006). 
 
Mechanical forces transmitted across the collagen molecule can lead to localized unfolding 
(micro-unfolding) (Bourne et al., 2014). In one domain of the protein, located in the N-terminus of 
the alpha1 chain, mechanical force exposes a chymotrypsin cleavage site. Mutations in this region, 
as seen in Ehlers-Danlos syndrome and osteogenesis imperfecta, significantly alter the unfolding 
kinetics of the collagen molecule (Makareeva et al., 2006). Tissue injury and remodelling of 
extracellular proteins can also result in conformational changes in this region of the collagen protein 
(Leikina et al., 2002; Persikov and Brodsky, 2002). 
 
Collagen is known to bind to cellular integrins via a cryptic epitope. This tripeptide 
sequence (arginine-glycine-aspartate or RGD) is exposed when collagen unfolds or is denatured 
(Engvall et al., 1978; Ingham et al., 1985). The RGD epitope plays a central role in the function of 
collagen as a cell signalling molecule and regulates cell proliferation and differentiation 
(Taubenberger et al., 2010). In MC3T3-E1 cells, partially denatured collagen engages α5β1- and αv-
integrins to promote phosphorylation of focal adhesion kinase (FAK), which eventually stimulates 
cell differentiation.  Unfolding has also been shown to transform collagen type I from a β1 integrin-
associated ligand to an αvβ3-dependent ligand due to exposure of an RGD epitope (Davis, 1992; 
Montgomery et al., 1994). A similar pathway has been identified for collagen-stimulated 
endothelial cell proliferation in angiogenesis (Ames et al., 2015). 
 
Clearly, the collagens are multi-function proteins that play an important role in the 
remodelling of the extracellular matrix. Much of the diversity seen with the protein originates from 
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cryptic epitopes that bind to a variety of proteins and receptors once the collagen molecule is 
partially unfolded. 
 
2.2. Fibronectin 
 
Two forms of fibronectin mediate a diverse array of biological effects. While the plasma 
form is involved in coagulation, most fibronectin functions are attributed to the less-soluble cellular 
form that interacts as part of the extracellular matrix. These functions include cell adhesion, growth, 
migration and differentiation as well as tissue responses to wound healing, malignant 
transformation, inflammation and haemostasis. There are various matricryptic sites within 
fibronectin, the majority of which are exposed following proteolysis (see Table 2 in Schenk et al.) 
(Schenk and Quaranta, 2003). However, there is evidence for unmasking of cryptic epitopes by 
partial unfolding. For example, incorporation of fibronectin in the extracellular matrix occurs by 
fibrillogensis, which involves self-association (polymerisation) of fibronectin into fibrils. Some of 
the sites mediating self-association are cryptic or partially cryptic and require conformational 
changes (such as mechanical stretching) to enable accessibility. Cell-driven increase in tension 
leads to unfolding and extension of the Fn III modules of the protein exposing cryptic 
polymerisation sites (Hao et al., 2005). Controlled strain experiments on fibronectin fibers show 
that stretch-induced exposure of cryptic sites increases gradually over the full range of fiber 
extension. This is accompanied by the onset of Fn III module unfolding (Klotzsch et al., 2009). The 
ability of fibronectin to unfold and reveal these sites is attributed to a lack of disulphide bonds in the 
Fn III modules, which imparts structural flexibility (Ohashi and Erickson, 2011). A partially cryptic 
disulphide isomerase activity has also been suggested in the C-terminal FnI12 module that may 
catalyse the cross-linking of disulphide bonds. This intrinsic rearrangement then facilitates the 
incorporation of fibronectin into the extracellular matrix (Langenbach and Sottile, 1999).  
 
2.3 Laminin 
 The laminins are a large family of matrix proteins that regulate cell adhesion, migration, 
proliferation and differentiation. They are heterotrimeric proteins with at least 15 different isoforms 
(DeBiase et al., 2006). Like many other extracellular matrix proteins, laminin is prone to unfolding 
under mechanical stress.  Using atomic force microscopy, Nemes and colleagues demonstrated a 
stepwise progression in laminin unfolding indicative, but not proof, of a modular structure to the 
protein (Nemes et al., 2002). Temperature-dependent unfolding of laminin has been widely reported 
and used to study its secondary structure. Brooks’ group used this approach to map cryptic epitopes 
within the molecules by screening for synthetic peptides that bound to the unfolded protein (Akalu 
et al., 2007).  The epitope recognised by the peptide was selectively exposed in melanoma tumor 
tissue but not in normal tissue. Importantly, blockade of the cryptic site in the tumor tissue led to 
attenuation of angiogenesis, tumor growth and metastasis. These findings not only suggested that 
laminin unfolds under physiological conditions but that the exposed cryptic epitopes following 
unfolding are central to tumorigenesis, at least for the melanoma model used in the study. 
 
 
 
3. Proteins not associated with the Extracellular Matrix 
 
 
3.1 Vitronectin 
 
The glycoprotein vitronectin is found in the circulation and has been associated with a range of 
functions including complement activation, coagulation and cell adhesion.  The molecule exists is 
several conformational states depending on its degree of unfolding. Native monomeric vitronectin 
interacts with thrombin-antithrombin complexes and glycoprotein IIb/IIIa while the unfolded 
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multimeric form binds to -endorphin, PAI-1, urokinase receptor and collagen (Seiffert and Smith, 
1997). This appears to be mediated through the somatomedin B domain in the N-terminal of the 
protein (Zhou, 2007). The native form does not bind integrins because the required RGD domain of 
vitronectin is buried adjacent to its N-terminal. Thus, perturbation of this region of the protein may 
expose the cryptic RGD site. Indeed, Seiffert and Smith have reported that PAI-1 binding to 
vitronectin activates the protein to recognise integrins (Seiffert and Smith, 1997). 
 Understanding cryptic epitopes not only reveals the intriguing functional diversity of 
proteins but also may identify potential drug targets. This is demonstrated with both laminin as 
described above and with vitronectin. Subtractive phage display technology has been used to 
identify antibodies that selectively bind to the unfolded active form of vitronectin but not to the 
native form (Bloemendal et al., 2004). Selectivity was demonstrated with intense immunostaining 
for the unfolded vitronectin in tumor tissue but not in normal tissue. 
 
3.2 Fibrinogen 
 
Fibrinogen is another extracellular protein that illustrates the role of cryptic sites. Of its 
multiple biological functions, clot formation is considered its primary role in vivo. Secondary 
physiological processes involve initiating, monitoring and managing inflammatory responses. 
Fibrinogen is a dimer comprised of three protein chains (α, β, and γ) containing three major 
structural regions: two D domains at the terminal ends of the chains and a centrally located E 
domain (Fig 2A). Conversion of fibrinogen to fibrin, a crucial event leading to exposure of these 
sites, occurs by thrombin-mediated removal of two pairs of fibrinopeptides (fibrinopeptides A & B) 
from the central region of the protein. This creates new N-terminal regions with exposed 
polymerisation sites required for the assembly of fibrin polymers in clot formation (Fig 2B). 
 
Thrombin cleavage alters the folded state, or secondary structure of the protein, which 
results in exposure of multiple sites that bind proteins and cells. Binding sites in the D region for 
plasminogen and tPA (Aα148–160 and γ312–324) have been described that are functional in fibrin 
but not fibrinogen. This was shown by the lack of binding by monoclonal antibodies raised 
specifically for each site (Schielen et al., 1991; Schielen et al., 1989). The sites were masked in 
fibrinogen and were exposed as a result of intermolecular interaction between the D and E region 
upon fibrin formation. Using a number of fibrinogen and fibrin derived fragments, it was shown 
that only D region fragments corresponding to their fibrin converted form bound plasminogen, tPA 
and monoclonal antibodies for these sites. In addition, binding occurred in fragments forming the 
intermolecular interaction between the D and E regions, but not upon their dissociation. This 
showed that a change in conformation of the D region upon interaction with region E made the 
binding sites accessible (Yakovlev et al., 2000). 
 
Conformational dependent cryptic sites are also found in other areas of the protein. As well 
as the three major domains comprising fibrinogen, there are also two compact surface associated 
regions called the αC-domains that interact with each other intramolecularly (Medved et al., 1985). 
Electron microscopy experiments showed that, upon fibrin formation, the conformation of the αC-
domains changes so that they dissociate and interact intermolecularly rather than intramolecularly 
(Gorkun et al., 1994; Veklich et al., 1993). The intermolecular interaction of the αC-domains then 
promotes the formation of thicker aggregated fibers required for clotting. This inter to intra-
molecular switch has also been shown to unmask sites within the αC-domains that bind 
plasminogen and tPA. As described for the D region, these sites only become accessible upon 
fibrinogen conversion to fibrin (Medved et al., 2001). Since fibrinogen does not bind tPA or 
plasminogen, these sites are cryptic in the fibrinogen αC-domains and only become available when 
the domains switch to their physiologically active conformation upon fibrin assembly (Tsurupa et 
al., 2011). 
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The list of cryptic binding sites within fibrinogen continues to expand. Similar binding 
studies using recombinant fragments along with ELIZA and surface plasmon resonance studies 
have more recently identified cryptic sites for alpha(2)antiplasmin in the D-region and C-terminal 
region of the αC-domain (Tsurupa et al., 2010), as well as a cryptic site for apolipoprotein(a) in the 
αC-domain of fibrinogen (Tsurupa et al., 2003). Fibrinogen also contains a cryptic integrin binding 
site located in the γC region of the D domain (Altieri et al., 1993; Lishko et al., 2004). Removal of 
the C-terminal tail of this region exposes the αMβ2 site (Mac-1) for binding to the Mac-1 receptor 
(Lishko et al., 2002). The interaction of the Mac-1 site with its corresponding receptor on cells 
induces a pro-inflammatory response. Importantly, access to the αMβ2 binding site has been shown 
to occur upon proteolytic cleavage of this tail or upon surface-induced immobilisation of fibrinogen 
(Lishko et al., 2002). This suggests that the masking of the αMβ2 binding site by the C-terminal tail 
can be removed by proteolysis or by conformational alteration. These observations together with the 
conformational flexibility exhibited by this C-terminal region (Mosesson et al., 2001; Yee et al., 
1997), has lead to a C-terminal “pull out” hypothesis (Yakovlev et al., 2000). Yakovlev and 
colleagues’ proposal articulates how this conformational transition could control access of ligands 
to several fibrinogen binding sites and thus regulate the functional interactions of fibrinogen. 
 
Many nanomaterials bind fibrinogen including metal oxides (Canoa et al., 2015; Deng et al., 
2009) silicates (Marucco et al., 2014), gold nanoparticles (Deng et al., 2013; Deng et al., 2012), 
carbon black (Kendall et al., 2011), polymeric spheres (Cedervall et al., 2007), and single-walled 
carbon nanotubes (Song et al., 2006). In addition, fibrinogen is a commonly reported constituent of 
the ‘hard corona’ of nanoparticle-protein complexes following exposure to biological environments 
(Aggarwal et al., 2009; Karmali and Simberg, 2011). Binding of proteins to nanomaterials is often 
associated with partial unfolding. This has been demonstrated for fibrinogen where its interaction 
with polymer-coated gold nanoparticles led to the unfolding of the γC region of the D-domain 
resulting in the exposure of the peptide sequence that binds to the Mac-1 receptor (Deng et al., 
2011). The extent of unfolding was dependent on the size of the nanoparticle as well as its charge 
(Deng et al., 2013). Moreover, other nanomaterials have been shown to elicit the same response 
(Deng et al., 2011). These observations are important as they provide a possible mechanistic basis 
for the inflammatory properties of some nanomaterials. However, they also suggest that precisely 
engineered nanoparticles may be a useful tool to identify and characterise cryptic epitopes in 
proteins associated with their surfaces. This principle has also been demonstrated with albumin, as 
outlined below. 
 
3.3 Albumin 
 
Albumin consists of a single polypeptide chain of 585 amino acids and is produced by the 
parenchymal cells of the liver. It is one of the few non-glycosylated serum proteins and the most 
abundant, constituting ~50% of the blood plasma volume. Albumin has been studied extensively 
due to its ability to reversibly bind and transport a vast array of molecules throughout the body, and 
hence influence multiple biological systems (Peters and Stewart, 2013). Albumin has several 
physiological functions, driven principally by its colloidal properties (Kragh-Hansen, 2013). Its 
primary function is to regulate blood volume by maintaining the colloid osmotic pressure of the 
blood compartment. It also influences fluid distribution of tissues providing 75% of the 
intravascular oncotic pressure (Doweiko and Nompleggi, 1991). Additional functions include a role 
in acid-base physiology owing to its 16 histidine imidazole residues (Agrafiotis et al., 2014; 
Watson, 1999), anti-oxidant properties by neutralising oxygen radicals (Anraku et al., 2013; Bruschi 
et al., 2013; Iwao et al., 2012), anticoagulation properties (Galanakis, 1992; Jorgensen and 
Stoffersen, 1979, 1980), and the binding and transport of ligands (Anand and Mukherjee, 2013; 
Dalvit et al., 2002; Sarver et al., 2005). 
 
 7 
 
The ability to unfold and refold (i.e conformational flexibility) is built into the structure of 
albumin so that it may alter its shape in response to changes in its environment (Kragh-Hansen et 
al., 2013). This allows albumin to bind many substances and operate as an excellent molecular 
chaperone (Anand and Mukherjee, 2013). The three-dimensional structure of albumin is often 
referred to as a globular heart-shape consisting of 3 homologous domains. These are subdivided 
into 2 contiguous helical subdomains A and B (Kragh-Hansen, 2013). The folding flexibility of 
albumin has been attributed to proline residues located between the subdomains that allow 
movement of one subdomain relative to another (Brown, 1976). Molecular flexibility also extends 
to the hydrophilic surface of the protein allowing a vast array of small molecules to bind. Because 
of the flexibility between subdomains, small molecule binding alters the spatial orientation between 
the subdomains which in turn affects the accessibility of other molecules for their binding sites 
(Quinlan et al., 2005).  
 
The high internal mobility of albumin also controls exposure of a cryptic epitope that 
provides anti-apoptotic protection to the endothelium (Bolitho et al., 2007). CNBr fragmentation of 
human serum albumin (HAS) was shown to significantly increase this anti-apoptotic activity, which 
is distinct from the known Cys34 radical scavenging mechanism. Conformational change of native 
albumin is required for exposure of the cryptic site, which is demonstrated by the ability of 
glycosylated HSA to inhibit the anti-apoptotic activity (Zoellner et al., 2009). The structural 
modifications produced in glycosylated HSA limit the high intramolecular flexibility of albumin, 
thus preventing cryptic site exposure.  
 
Chemically-modified albumin is targeted to cell surface scavenger receptors where it is 
cleared from the circulation (Mikulikova et al., 2005). The major scavenger receptor involved 
appears to be SR-B1 (Binder et al., 2012; Miyazaki et al., 2002). The exact mechanism remains to 
be determined, but may involve the modified region of the protein or unfolding induced by the 
covalent binding of the chemical to the protein.  Native albumin is not a ligand for the scavenger 
receptor family. By contrast, native albumin bound to the surface of various nanomaterials is 
recognised by scavenger receptors. It was initially suspected that nanoparticle bound albumin was 
‘structurally damaged’ (Dutta et al., 2007). However, more recent studies have shown the unfolding 
of albumin is a critical step. Studies by Mortimer et al. (Mortimer et al., 2014) and Fleisher et al. 
(Fleischer and Payne, 2014) demonstrate that changes to the secondary structure of albumin due to 
nanoparticle binding directs recognition by receptors and hence uptake into cells. Anionic 
polystyrene nanoparticles bound with albumin were internalised by albondin expressing cells, while 
cationic nanoparticles bound albumin and were taken up by scavenger receptor expressing cells 
(Fleischer and Payne, 2014). Mortimer and colleagues show that the binding of albumin to anionic 
layered silicate nanoparticles targets the nanoparticle-albumin complex to scavenger receptors 
(Mortimer et al., 2014). Circular dichroism demonstrated how the loss of helical content (i.e change 
in secondary structure) controls the recognition of complexes by scavenger receptors.  Much work 
has been done at the molecular level to characterise the binding sites of albumin for various 
molecules as well as how the binding of these molecules alters structural conformation and 
functionality of the protein (Kragh-Hansen et al., 2013). Changes in protein conformation can be 
accompanied by the exposure of new peptide sequences. As pointed out by Fleisher et al., 
separating epitope exposure from altered protein conformation is difficult.  Mortimer et al. 
addressed this by showing that an alternate process to nanoparticle-induced unfolding of albumin, 
heat denaturation, could similarly expose an epitope that bound to scavenger receptors. 
Furthermore, separate expression of each of the three albumin domains revealed that domains I and 
II were recognised by scavenger receptors to a greater extent following either heat denaturation or 
binding to nanoparticles. These insights suggest that the well-known clearance of structurally 
damaged albumin from the circulation by macrophages is a result of cryptic epitopes designed to be 
detected by specific changes in protein structure. That the structural changes must be specific are 
highlighted by the fact that not all foreign material that binds albumin leads to scavenger receptor 
 8 
 
recognition, as Fleisher et al. demonstrated by the unaltered secondary structure of albumin 
following binding to anionic polystyrene particles. 
 
These findings indicate that the unfolding dynamics of albumin upon interaction with 
various surfaces serves to expose hidden epitopes, expanding the functionality of albumin to include 
a means of clearing various particles from the circulation via the scavenger receptor system. This 
example also demonstrates how cryptic site exposure operates in conjunction with related pattern 
recognition receptors to regulate cell responses - a proposal put forward by Davis et al. for 
extracellular matrix proteins and the recognition of matricryptic sites by pattern recognition 
receptors involved in tissue injury responses (Davis, 2010). 
 
3.4 Complement Factor H 
 
Complement factor H is a 150 kDa glycoprotein of the complement control protein 
superfamily (Perkins et al., 2010). It is included in this review because it has several binding sites 
for different ligands whose accessibility is dependent on unfolding of the protein. The molecule 
consists of 20 complement control protein domains connected by short linkers of 3-8 amino acid 
residues. Complement control protein domains enable folding flexibility that control interactions 
with other proteins and hence functionality (Okemefuna et al., 2009; Oppermann et al., 2006). 
Factor H functions as a complement regulator essential for controlling complement activation in 
plasma and on cell surfaces (Perkins et al., 2010). Complement is part of the innate immune system 
that provides a defence mechanism against pathogens such as bacteria. Complement activation can 
be initiated by three pathways: the classical, lectin or alternative pathways. The cascading events in 
each of these pathways ultimately generate the central complement component, C3 convertase, 
which produces C3b molecules (Ricklin et al., 2010). Factor H has the critical role of regulating 
C3b so that host protection against pathogens occurs without C3b over-activated damage to host 
cells (Bajic et al., 2015). Factor H controls C3b activity by inhibiting binding of components with 
C3b and by participating in its inactivation through proteolytic cleavage. Factor H presents five 
major ligand interactions that influence its complement regulatory activity, recently reviewed by 
Miller and colleagues (Perkins et al., 2012). The ligands include C3b, C3d, heparin, C-reactive 
protein, zinc and itself by self-association. There are 2 binding sites for each ligand except zinc 
which has several weak interaction sites. In addition, a third binding site for C3b has been proposed 
(Schmidt et al., 2008). Binding of heparin, C3d and C-reactive protein to Factor H regulates 
complement activation at host cell surfaces whereas zinc binding inhibits the regulatory activity of 
Factor H by promoting its aggregation (Perkins et al., 2012). Importantly, these binding sites are 
cryptic within Factor H, requiring specific conformational arrangement of the protein to enable 
accessibility (Morgan et al., 2011). A model of Factor H unfolding depicts the native protein as a 
compact structure with only the C-terminal domain binding sites for C3b, C3d and heparin 
accessible. Binding of ligands to the C-terminal domain initiates unfolding, exposing additional 
sites that facilitate further ligand binding and alteration in conformation (Oppermann et al., 2006). 
Bacterial proteins such as PspC from Streptococcus pneumoniae bind with high affinity to 
Factor H and induce a conformational change that exposes a second cryptic binding domain for the 
C3b fragment of C3 (Herbert et al., 2015). The resulting complex enhances the functionality of 
Factor H as a suppressor of the complement system. 
 
4 Cryptic epitopes and evolutionary conservation 
 
Functional epitopes, whether explicitly displayed on the surface of a protein or hidden within its 
structure, may show evolutionary conservation if they are important for the physiological role of the 
protein. However, identifying these epitopes can be challenging depending on whether they are 
represented by a linear peptide sequence or a motif involving structural elements in close proximity. 
An excellent example of cryptic structural motifs with evolutionary conservation is the regions 
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within the HIV-1 envelope glycoprotein that mediate cellular interactions required to infect target 
cells. These regions or epitopes provide the attachment and fusion points to target cells and hence 
are resistant to variation by selective pressure (Wyatt et al., 1998). Therefore the virus evolved the 
cryptic nature of these epitopes as a protective mechanism. This is shown by the conformational 
flexibility of the structures containing the binding regions that keep the sites hidden and only 
become accessible following certain sequential interactions (Rizzuto et al., 1998; Sullivan et al., 
1998; Wu et al., 1996). Additional crypticity is provided by variable loops that mask these regions 
(Lusso et al., 2005; Wyatt et al., 1995) as well as considerable surface glycosylation to evade 
epitope recognition by the immune system (Wyatt et al., 1998). 
 
Between species, protein homology is highest in those regions of functional importance as 
structural homology often parallels sequence homology (Schmitt et al., 2002). By contrast, regions 
of proteins that are buried tolerate lower sequence similarity so long as structure is maintained. 
Thus, buried sequences of high homology infer a physiological function.  For cryptic epitopes, or 
matricryptic sites, that are linear and physiologically relevant, evolutionary conservation would be 
expected. This is demonstrated with the amino acid sequence in the γC region of the fibrinogen 
molecule that engages the Mac-1 receptor (Deng et al., 2011). The epitope is exposed following 
local unfolding. Alignment of the fibrinogen C chain from 15 vertebrate species shows greatest 
homology (>90%) at the sequence for the Mac-1 receptor binding epitope (Fig 3A). By contrast, 
homology is markedly lower in the flanking regions. This is an interesting observation that supports 
a physiological role for the cryptic epitope, as opposed to an aberrant response to protein unfolding. 
While evolutionary conservation does not prove that a buried region in a protein may have an effect 
if exposed, it does provide leads when the tools for discovering such sequences are lacking. When it 
was discovered that albumin could unfold and recognise the scavenger receptor, the binding 
epitopes were not specifically identified but several regions were suggested based on their anionic 
properties – amino acids 56-63, 249-256 and 292-301 (Mortimer et al., 2014). Alignment of these 
regions from 17 different vertebrate species (Fig 3B) shows good homology in the first sequence 
(85-90%), excellent homology in the second sequence (95-100%), but poor homology in the third 
sequence (~ 70%). This bioinformatics approach, in combination with site-directed mutagenesis, 
may assist in identifying potential cryptic epitopes in the future. 
 
5 Nanoparticles and protein unfolding 
 
 Nanoparticles possess many unique properties that are the basis for their novel uses in 
engineering, product development, material science and medicine. For nanoparticles intended for 
medical applications, protein binding to their surface is well recognised as a major limitation. 
Surface-bound proteins not only alter the essential properties of the nanoparticles but can also 
determine their fate in vivo (Butcher et al., 2016; Hadjidemetriou et al., 2015; Sahneh et al., 2015; 
Schottler et al., 2016). However, as discussed above with fibrinogen and albumin, nanoparticles 
may provide a useful tool to identify and characterise cryptic epitopes in many different proteins. 
This concept was first proposed by Lynch et al (Lynch et al., 2006) and is dependent on the surface 
curvature and composition of the nanoparticle. As proteins bind, they can spread across the 
nanoparticle surface. While this results in a corona of protein adhering to the nanoparticle surface, it 
can also result in protein unfolding and exposure of cryptic epitopes. Proteins bound to 
nanoparticles often exhibit characteristics not normally associated with them, such as aggregation, 
receptor interaction and immunogenicity (Monopoli et al., 2012). When bound proteins are 
transformed into ligands for specific cell-surface receptors to which they do not normally interact, 
then the unfolding process on the surface of the nanoparticle is likely to have revealed a cryptic 
epitope. This has been the explanation for the binding of fibrinogen to the Mac-1 receptor and 
albumin to the scavenger receptor when associated with nanoparticles (Deng et al., 2011; Mortimer 
et al., 2014).  
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 Aggressive unfolding of many proteins exposes internal hydrophobic domains that cause 
rapid aggregation in an aqueous environment. When this occurs in vivo, toxic amyloidosis can 
result. Proteins such as b2-microglobulin aggregate following unfolding on various nanoparticle 
(Linse et al., 2007). However, with precisely engineered particles with different sizes and surface 
potentials, it may be possible to screen for epitopes by inducing more subtle unfolding. This was 
elegantly demonstrated with the partial unfolding of transferrin bound to polystyrene nanoparticles 
(Kelly et al., 2015). The challenge is to develop appropriate screening techniques that can identify 
functional epitopes following unfolding. 
 
6 Conclusions 
 
The identification of physiologically functional cryptic epitopes is increasing in the 
literature both for extracellular and intracellular proteins. The unfolding or conformational change 
required to unmask these epitopes is a process distinct from the more commonly described 
proteolytic cleavage mechanism. Unfolding is an important feature relevant to protein functionality 
because it can allow for refolding dynamics that cleavage events cannot. Furthermore, protein 
unfolding/refolding provides a crucial way of regulating the functionality of proteins and hiding 
biological activity until it is required. The extent to which a cryptic site is masked (i.e. the amount 
of folding required to keep it hidden) may also control biological activity. These factors may control 
the conformation constraints upon the secondary structure thus contributing to the extent to which a 
hidden site may be buried. There is also evidence to suggest that binding sites can be hidden as 
opposed to exposed upon unfolding. 
 
There are many questions that need answering to further our knowledge in this field. 
Importantly, the experimental tools that will allow for the identification of important sites still need 
to be developed. The examples of nanoparticle induce-unfolding discussed in this review present 
the opportunity for using nanoparticles as a tool to study proteins and how they unfold in different 
environments. Using nanomaterials in this way is a more sophisticated and subtle method of 
providing an environment to induce unfolding than surface immobilisation or heat denaturation 
which can influence the entire protein. 
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Legend to Figures 
 
Figure 1. Representation of how buried sequences can be uncovered following unfolding induced 
by various factors such as mechanical forces or protein-protein interactions. Primary function of the 
protein is attributed to sites accessible when the protein is in its normal folded state. Secondary 
functions, which may be entirely different to the primary function, are only revealed following 
unfolding. Importantly, this process is reversible. 
  
 19 
 
 
Figure 2. Cryptic epitopes in fibrinogen. A. The fibrinogen protein comprises 3 chains that are 
duplicated around a hinge region (E domain). A cryptic epitope that binds to the Mac-1 receptor is 
present in the -nodule. B. The protein polymerises by intermolecular interactions between the D 
domain and the E domain of the protein. 
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Figure 3. Conservation of buried sequences that comprise a cryptic epitope. A. The Mac-1 receptor 
binding sequence (black bar) in the C chain of fibrinogen is conserved across 15 different vertebrate 
species. This contrasts with flanking sequences where conservation is much less. B. Three anionic 
sequences buried in the albumin molecule and have been suggested as possible cryptic sites for 
scavenger receptor interactions (Mortimer et al., 2014). Two of these sequences (Albumin I: 56-63, 
Albumin II: 249-256) show high conservation between 17 vertebrate species while the third 
(Albumin III: 292-301) does not. 
 
 
